{
  "label": "clinical_signal_03_dx_pain_management_trial_005",
  "artifact_type": "distractor_episode",
  "artifact_id": "sha256:154d55d80bb9dda26d70daddc37c3d992f8eaf2d438751d3687f047d55378797",
  "input_ids": [
    "sha256:b4ba5337b06c8de68ac3315db1a4f6980c5bd48efd529c3914f30297d6afd329",
    "sha256:d2554312b101640799bbcc7f256f50a08066d33a9ccbb4427d48a8bc70854eff"
  ],
  "prompt_id": null,
  "model_config": null,
  "created_at": "2026-02-17T11:58:38.424838",
  "content": "## 2024-04-01 Daily Operations Summary\n\n### Enrollment\n- Total Enrolled: 83\n- Active: 83\n- Screen Failures Cumulative: 14\n- Withdrawals Cumulative: 0\n- By Treatment Arm: \n  - Multimodal: 28\n  - Standard: 28\n  - Placebo: 27\n\n### Efficacy By Arm\n- Multimodal: \n  - VAS Pain Score Mean: 6.0\n  - VAS Pain Score SD: 1.7\n  - Morphine Equivalents mg Mean: 40.2\n  - Morphine Equivalents mg SD: 10.0\n  - Six MWT Meters Mean: 307.0\n  - Six MWT Meters SD: 36.0\n  - Grip Strength kg Mean: 22.5\n  - Grip Strength kg SD: 4.4\n  - Sleep Quality Index Mean: 4.8\n  - Sleep Quality Index SD: 1.3\n  - Rescue Med Doses per Week Mean: 4.1\n  - Rescue Med Doses per Week SD: 1.1\n- Standard: \n  - VAS Pain Score Mean: 6.4\n  - VAS Pain Score SD: 1.4\n  - Morphine Equivalents mg Mean: 46.7\n  - Morphine Equivalents mg SD: 10.6\n  - Six MWT Meters Mean: 283.0\n  - Six MWT Meters SD: 44.0\n  - Grip Strength kg Mean: 21.1\n  - Grip Strength kg SD: 4.7\n  - Sleep Quality Index Mean: 4.0\n  - Sleep Quality Index SD: 1.3\n  - Rescue Med Doses per Week Mean: 5.4\n  - Rescue Med Doses per Week SD: 2.4\n- Placebo: \n  - VAS Pain Score Mean: 6.5\n  - VAS Pain Score SD: 1.3\n  - Morphine Equivalents mg Mean: 45.8\n  - Morphine Equivalents mg SD: 7.4\n  - Six MWT Meters Mean: 253.0\n  - Six MWT Meters SD: 56.0\n  - Grip Strength kg Mean: 19.3\n  - Grip Strength kg SD: 4.8\n  - Sleep Quality Index Mean: 3.7\n  - Sleep Quality Index SD: 1.5\n  - Rescue Med Doses per Week Mean: 6.9\n  - Rescue Med Doses per Week SD: 1.3\n\n### Physical Therapy\n- Sessions Scheduled: 169\n- Sessions Attended: 142\n- Attendance Rate %: 90.4\n\n### Safety Labs\n- Hemoglobin g/dL Mean: 13.8\n- Hemoglobin g/dL SD: 1.0\n- WBC k Mean: 8.0\n- WBC k SD: 1.8\n- Platelets k Mean: 237\n- Platelets k SD: 43\n- Serum Creatinine mg/dL Mean: 1.0\n- Serum Creatinine mg/dL SD: 0.18\n- Blood Glucose mg/dL Mean: 99.0\n- Blood Glucose mg/dL SD: 18.0\n- ESR mm/hr Mean: 8.0\n- ESR mm/hr SD: 8.0\n\n### Adverse Events\n- AE ID: PM-AE-0547, Description: urinary retention, Grade: 1, Relatedness: possibly related, Resolved: true, Treatment Arm: multimodal\n- AE ID: PM-AE-0565, Description: dry mouth, Grade: 1, Relatedness: unlikely related, Resolved: true, Treatment Arm: multimodal\n- AE ID: PM-AE-0528, Description: nausea, Grade: 1, Relatedness: unlikely related, Resolved: true, Treatment Arm: standard\n\n### Protocol Deviations\n- No protocol deviations reported.\n\n### Events\n- Pain diary electronic collection rate: 95%\n- Physical therapy schedule coordinated across 15 sites\n\n### Notes\n- Week 5: Pain management assessments on track. 83 subjects enrolled across treatment arms. Functional outcomes within expected ranges.",
  "metadata": {
    "episode_type": "distractor",
    "theme": "pain_management_trial",
    "theme_index": 2,
    "local_index": 5,
    "scope_id": "clinical_signal_03",
    "layer_name": "distractor_episodes",
    "layer_level": 2,
    "build_fingerprint": {
      "scheme": "synix:build:v1",
      "digest": "04d281e565ab973ef60b0f0293e5fbf9df06f5b5e94711c3be514e4cfd463dff",
      "components": {
        "transform": "a88665a5359d5ac5d2c858c77a2a19318c209adeea6fae2b838d79e11f6aba2b",
        "inputs": "9089c542b39a8d40"
      }
    },
    "transform_fingerprint": {
      "scheme": "synix:transform:v2",
      "digest": "a88665a5359d5ac5d2c858c77a2a19318c209adeea6fae2b838d79e11f6aba2b",
      "components": {
        "transform_id": "01137a4997b78f86",
        "source": "c42d9c6282d5331f",
        "model": "1e2ccf75e96d7ee7"
      }
    }
  }
}